1. | rzoro41 | |
2. | metalbarha | |
3. | amay464 | |
4. | wantgoodone |
1. | rzoro41 | |
2. | metalbarha | |
3. | amay464 | |
4. | wantgoodone |
1. | wantgoodone 09/13/2018 FDA has granted Fast Track designation for the company’s anti-CTGF antibody, pamrevlumab |
2. | metalbarha 06/04/2018 Presents clinical results of Pamrevlumab; |
3. | rzoro41 02/27/2018 Still!! |
4. | rzoro41 03/01/2018 Fibrogen Granted Fast Track Designation by U.S. FDA for Pamrevlumab Treatment of Patients with Locally Advanced Unresectable Pancreatic Cancer |
5. | amay464 06/03/2018 FibroGen Presents Clinical Results of Pamrevlumab Treatment in Patients with Locally Advanced Unresectable Pancreatic Cancer at ASCO 2018 Annual Meeting |